HANNAH HOUSTON: Open Payments
NPI 1437926912 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 29 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $490 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $96 |
| ABBVIE INC. | 5 | $92 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| SHIELD THERAPEUTICS INC | 2 | $32 |
| Lilly USA, LLC | 2 | $32 |
| Amgen Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Viatris Specialty LLC | 1 | $22 |
Products named: REXULTI, Ozempic, AIRSUPRA, VRAYLAR, ACCRUFER, MOUNJARO, EVENITY, QULIPTA.
Industry payments across NC — which companies pay providers there.
